BGI and MGI recently announced a clinical lab partnership program designed to accelerate population-level testing to help fight the ongoing pandemic. The companies are leading global suppliers of COVID-19 RT-PCR test kits and automated sample preparation systems, including sample transfer and viral RNA extraction.
The program empowers accredited labs with high-quality, readily available technology so they can focus on maximizing productivity.
“In addition to delivering a world-class technology solution for COVID-19 testing programs like Task Force Lab’s, we are pleased to assure our partners that they have access to near limitless testing supplies, both extraction and detection, at a crucial time during this pandemic,” said Jeremy Nickolenko, head of global commercial partnerships for BGI-MGI. “Lack of testing reagents in this country is a myth. Having high-accuracy technology available in local warehouses now has helped TFL and other lab partners offer 24- to 48-hour turnaround times so their customers can get back to normal activity safely.”
The program is now open for accredited labs to join and includes benefits such as:
• Continuous supply of critical reagents
• Immediate access to emergency use authorization COVID-19 assay
• Lab automation to maximize throughput
• Premier customer and technical support
Task Force Lab, a founding member of the program, is bringing full-service, concierge testing directly to customers.
“We started TFL to address the shortage of COVID-19 testing and we’re thrilled to be partnered with BGI and MGI to provide our full service, on-site testing solution in an effort to create a safe environment for clients in a number of sectors, including government, sports, nursing homes, schools and universities, production studios and so on,” said Pasadena resident Erik Bogaard, co-founder of TFL. “Given our unique approach toward not overbooking lab capacity and our coordination of on-site sample collection, TFL is perfectly positioned to provide clients with the convenience and guaranteed turnaround time needed to protect their communities.”
TFL recently announced a partnership with the Association of Volleyball Professionals to facilitate and lead all testing procedures for the 2020 AVP
Champions Cup Series. In order to provide reliable diagnostic testing, TFL via a clinical laboratory, processed results in around 24 hours, allowing the AVP to provide the best possible testing protocols to athletes and staff.
“Our partnership with TFL not only brought to the table experience in COVID-19 testing, but true collaborative partners who facilitated and led all logistics within a time frame that allowed us the best possible safety standards were met,” said Al Lau, AVP’s chief operating officer. “TFL delivered on all fronts and I’m pleased to have found partners that share our same values, integrity and commitment to the cause.”
TFL uses the BGI RT-PCR Kit for detecting COVID-19 as well as the MGI viral RNA extraction system, all covered by the Food and Drug Administration emergency use authorization. Combined, this scalable, high-throughput workflow solution enables TFL to meet all current and future testing demand. The BGI RT-PCR kit was among the first COVID-19 molecular assays to be authorized by the FDA.